PharmacyCodes



Gliclazida [INN-Spanish] en es it fr

Gliclazida [INN-Spanish] Brand names, Gliclazida [INN-Spanish] Analogs

Gliclazida [INN-Spanish] Brand Names Mixture

  • No information avaliable

Gliclazida [INN-Spanish] Chemical_Formula

C15H21N3O3S

Gliclazida [INN-Spanish] RX_link

No information avaliable

Gliclazida [INN-Spanish] fda sheet

Gliclazida [INN-Spanish] msds (material safety sheet)

Gliclazida_[INN-Spanish] MSDS

Gliclazida [INN-Spanish] Synthesis Reference

No information avaliable

Gliclazida [INN-Spanish] Molecular Weight

323.412 g/mol

Gliclazida [INN-Spanish] Melting Point

181 oC

Gliclazida [INN-Spanish] H2O Solubility

No information avaliable

Gliclazida [INN-Spanish] State

Solid

Gliclazida [INN-Spanish] LogP

2.418

Gliclazida [INN-Spanish] Dosage Forms

Tablet

Gliclazida [INN-Spanish] Indication

For the treatment of Diabetes mellitus

Gliclazida [INN-Spanish] Pharmacology

Gliclazide is a second generation sulphonylurea which acts as a hypoglycemic agent. It stimulates beta cells of the islet of Langerhans in the pancreas to release insulin. It also enhances peripheral insulin sensitivity. Overall it potentiates insulin release and improves insulin dynamics.

Gliclazida [INN-Spanish] Absorption

Rapidly and well absorbed but may have wide inter- and intra-individual variability.

Gliclazida [INN-Spanish] side effects and Toxicity

LD50=3000 mg/kg (orally in mice)

Gliclazida [INN-Spanish] Patient Information

No information avaliable

Gliclazida [INN-Spanish] Organisms Affected

Humans and other mammals